-
Symbol
-
PRME on Nasdaq
-
Investment type
-
Equity / Common Stock, $0.00001 par value
-
Latest Disclosed Ownership
-
6.11M shares
-
Security Ownership
-
4.7%
Newpath Partners, L.P. ownership in Prime Medicine, Inc. Common Stock, $0.00001 par value (PRME)
2025-02-14 - Newpath Partners, L.P. has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 6.11M shares of Prime Medicine, Inc. Common Stock, $0.00001 par value (PRME).
This represents 4.7% percent ownership of the company.